Christopher Pierce
Keine laufenden Positionen mehr
Karriereverlauf von Christopher Pierce
Ehemalige bekannte Positionen von Christopher Pierce
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Corporate Officer/Principal | 01.07.2020 | 30.09.2021 |
| Scout Advisers LLC | Corporate Officer/Principal | 01.08.2019 | 01.07.2020 |
| LOXO ONCOLOGY INC | Corporate Officer/Principal | 01.04.2017 | 01.05.2019 |
| PFIZER, INC. | Corporate Officer/Principal | 01.07.2016 | 01.03.2017 |
Ausbildung von Christopher Pierce
| Harvard Business School | Masters Business Admin |
| Harvard College | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Corporate Officer/Principal | 4 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
| Scout Advisers LLC |
- Börse
- Insiders
- Christopher Pierce
- Erfahrung